A joint attention-based deep learning system provides good predictive performance for differentiating autism spectrum disorder (ASD) from typical development (TD), according to a study published online May 25 in JAMA Network ...
May 31, 2023
0
8
Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single center study, published in Regional Anesthesia & Pain Medicine.
May 30, 2023
0
8
People with sight loss in the UK are confused by a "disjointed" certification and registration system that "creates a barrier" for people trying to access support, benefits and rehabilitation, a new academic study has reported.
May 24, 2023
0
2
Cases of vision loss and deaths are mounting in an investigation into eye drops contaminated with a rare strain of the drug-resistant bacteria, Pseudomonas aeruginosa.
May 23, 2023
0
9
Sudden, painless loss of vision. Burning back pain. Achy legs. Incontinence.
May 19, 2023
0
56
An estimated 295 million people suffer from visual impairment globally. Around 43 million of those people are living with blindness. While not every form of blindness can be cured, recent scientific breakthroughs have uncovered ...
May 12, 2023
0
9
Researchers from Aston University and the University of York have discovered new insights into how the human brain makes perceptual judgements of the external world.
May 9, 2023
0
97
There's new hope for potentially restoring vision in patients suffering from degenerative retinal disease, thanks to work by researchers at Université de Montréal.
May 5, 2023
0
472
Researchers at the Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute at the Cleveland Clinic in Ohio have authored a case report on the positive effects of psilocybin on color blindness.
A successful gene therapy trialed at Michigan State University in dogs with an inherited eye disease is ready to be developed for clinical use in human patients with a rare condition called retinitis pigmentosa.
Apr 26, 2023
0
289
